Dermatology Times Newsletter

To view this email as a web page, click here.

FDA approves Tafinlar with Mekinist for melanoma

The U.S. Food and Drug Administration recently approved Novartis’ Tafinlar (dabrafenib) with Mekinist (trametinib) for adjuvant treatment of melanoma with BRAF V600E and V600K mutations.

Cimzia receives positive CHMP opinion for plaque psoriasis

UCB’s Cimzia (certolizumab pegol) was recommended for approval by the European Committee for Medicinal Products (CHMP) for the treatment of adult patients with moderate-to-severe plaque psoriasis.

5 Keys to Strong Business Relationships

Looking for how to build strong business relationships? Here's a checklist to help you connect more effectively with current and potential partners.

JOB OPPORTUNITIES

AZ - Integrated Dermatology

CO - Leavitt Management Group

CT - Integrated Dermatology

FL - Integrated Dermatology

FL - Leavitt Management Group

GA - Leavitt Management Group

IL - Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MI - Leavitt Management Group

National - Integrated Dermatology

NC - Integrated Dermatology

NJ - Integrated Dermatology

OR - Cynthia Dreyer MD

PA - Leavitt Management Group

PA - Integrated Dermatology

PA - Milton S Hershey Medical Center

RI - Leavitt Management Group

TN - Integrated Dermatology

TX - Company Confidential

VA - Integrated Dermatology

WY - Leavitt Management Group

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT